Fenofibric acid | m-entrepreneurship.com

Product Name :
Fenofibric acid

Search keywords :
Fenofibric acid

drugId :
null

Target Vo:
Peroxisome proliferator-activated receptor α

Target Vo Short Name :
PPARα

Moa_Name:
Peroxisome proliferator-activated receptor α agonists

First Approval Country :
United States

First Approval Date Filter:
2009

Origin Company_Name :
Hanmi Pharmaceutical Co Ltd

Active Company_Name :
Hanmi Pharmaceutical Co Ltd

Active Indication_Name:
Hyperlipidemias

In Active Indication_Name:
Hypertriglyceridemia

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
LRP1 Antibody
Fatty Acid Synthase Antibody
WDR77 Antibody (YA655): WDR77 Antibody (YA655) is a non-conjugated and Mouse origined monoclonal antibody about 37 kDa, targeting to WDR77 (8A10). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts